trial · primary record
IV Tulisokibart
Crohn's Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1200 |
| Primary completion | 2029-11-12 |
| Primary endpoint | Study 1 [US/FDA Only]: Percentage of Participants Achieving Clinical Remission per Crohn's Disease Activity Index (CDAI) Score at Week 52 |
| Registry ID | NCT06430801 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:25.538Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06430801
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.